Table 5.
Advantages and limitations of current screening methods
Methods | Efficiency | Insufficiency or drawbacks | Reference |
---|---|---|---|
FOBT or FIT |
Easiest, least expensive method for screening Reduces cancer mortality 15% to 33% Specificity ranging from 88% to 98% |
Detects only 30-40% of CRC Detects 10% of late stage adenomas |
18-24 |
sDNA | Sensitivity ranging from 52% to 91% Specificity ranging from 93% to 97% |
Detects only late stage lesions | 25-29 |
FSIG | Directly inspects the mucosal surface Ability to resect identified abnormalities Reduces CRC mortality |
Fails to detect polyps in the proximal colon, where 40% of all cancers occur, Fails to detect 10-15% sigmoid colon cancers | 30-40 |
COL | Directly inspects the mucosal surface Ability to resect identified abnormalities Reduces CRC mortality Ability to perform interventions for other diseases Current gold standard for detection and treatment |
Invasive and time consuming Requires bowel preparation Costly Carries risk of perforation or death May miss up to 10-20% of polyps < 1 cm |
41-53 |
DCBE | Sensitivity for detecting polyps and cancer are about 70% and 85%, respectively Less invasive procedure |
Doesn't permit removal of identified abnormalities Less specific screening test |
54-56 |
CTC | Sensitivity for detecting adenomas ≥5 mm ranging from 65-72% Sensitivity for detecting larger adenomas ranging from 80-85% Less invasive than COL |
Delivers a significantly higher amount of radiation exposure (2-4 rad) than routine chest radiograph (0.5 rad) | 57-62 |